Low-dose-rate brachytherapy for prostate cancer: Preplanning vs. intraoperative planning-Preplanning is best

Brachytherapy

Volumn 5, Issue 3, 2006, Pages 139-142

  Blasko, John C ^a  

^a Seattle Prostate Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33746062385     PISSN: 15384721     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brachy.2006.04.004     Document Type: Note

References (14)

1. Blasko J.C., Radge H., and Schumacher D. Transperineal percutaneous iodine-125 implantation for prostatic carcinoma using transrectal ultrasound and template guidance. Endocurie Hypertherm Oncol 3 (1987) 131-139
2. Stock R.G., Stome N.N., Dahlal M., et al. What is the optimal dose for I-125 prostate implants? A dose-response analysis of biochemical control, posttreatment prostate biopsies, and long-term urinary symptoms. Brachytherapy 1 (2002) 83-89
3. Potters L., Cao Y., Calugaru E., et al. A comprehensive review of CT-based dosimetry parameters and biochemical control in patients treated with permanent prostate brachytherapy. Int J Radiat Oncol Biol Phys 50 (2001) 605-614
4. Merrick G.S., and Butler W.M. Modified uniform seed loading for prostate brachytherapy: Rationale, design, and evaluation. Tech Urol 6 (2000) 8-84
5. Wilkinson D.A., Lee E.C., Ciezki J.P., et al. Dosimetric comparison of pre-planned and OR-planned prostate seed brachytherapy. Int J Radiat Oncol Biol Phys 48 (2000) 1241-1244
6. Shanahan T.G., Nanavati P.J., Mueller P.W., et al. A comparison of permanent prostate brachytherapy techniques: Preplan vs. hybrid interactive planning with postimplant analysis. Int J Radiat Oncol Biol Phys 53 (2002) 490-496
7. Zelefsky M.J., Yamada Y., Marion C., et al. Improved conformality and decreased toxicity with intraoperative computer-optimized transperineal ultrasound-guided prostate brachytherapy. Int J Radiat Oncol Biol Phys 55 (2003) 956-963
8. Merrick G.S., Butler W.M., Dorsey A.T., et al. Effect of prostate size and isotope selection on dosimetric quality following permanent seed implantation. Tech Urol 7 (2001) 233-240
9. Grimm P.D., Blasko J.C., Sylvester J.E., et al. Technical improvement in permanent seed implantation: A two-stage brachytherapy system. Description and comparison with current technique. Brachytherapy 3 (2004) 34-40
10. Blasko JC, Grimm P, Sylvester JE. Dosimetric outcomes vs. prostate volume. 10th Annual Conference. Seattle, WA: Seattle Prostate Institute; 2003.
11. Lee W.R., deGuzman A.F., Bare R.L., et al. Postimplant analysis of transperineal interstitial permanent prostate brachytherapy: Evidence for a learning curve in the first year at a single institution. Int J Radiat Oncol Biol Phys 46 (2000) 83-88
12. D'Souza W.D., Thames H.D., and Kuban D.A. Dose-volume conundrum for response of prostate cancer to brachytherapy: Summary dosimetric measures and their relationship to tumor control probability. Int J Radiat Oncol Biol Phys 58 (2004) 1540-1548
13. Han B.H., Wallner K., Merrick G., et al. Prostate brachytherapy seed identification on post-implant TRUS images. Med Phys 30 (2003) 898-900
14. Todor D.A., Zaider M., Cohen G.N., et al. Intraoperative dynamic dosimetry for prostate implants. Phys Med Biol 48 (2003) 1153-1171